AI assistant
Medpace Holdings, Inc. — Director's Dealing 2019
Jan 23, 2019
30442_dirs_2019-01-23_e06ca1d9-a0c7-42a3-98fc-2c5b23e43ce8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2019-01-18
Reporting Person: Medpace Investors, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-18 | Common Stock | S | 38318 | $61.43 | Disposed | 8096225 | Direct |
| 2019-01-22 | Common Stock | S | 9936 | $61.10 | Disposed | 8086289 | Direct |
| 2019-01-23 | Common Stock | S | 24160 | $61.22 | Disposed | 8062129 | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2018.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.91. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.31. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F4: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $61.00 to $61.79. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.